Watchdog Asks Court To Reject BioXcel Ch. 11 Plan Releases

By Emily Lever · October 19, 2026, 9:17 PM EDT

The U.S. Trustee's Office is urging a Delaware bankruptcy judge to reject AI-bolstered pharmaceutical group BioXcel's Chapter 11 plan disclosure statement ahead of a hearing Wednesday, arguing the plan contains nonconsensual third-party...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

BioXcel Therapeutics, Inc.

Case Number

1:26-bk-11360

Court

Delaware

Nature of Suit

Date Filed

August 27, 2026